Clinical Trial Site

München

1 studies enrolling now · 2 studies all time

What they study most

AQP4+ NMOSD, Atypical Hemolytic Uremic Syndrome (aHUS), NMOSD, Neuromyelitis Optica Spectrum Disorder

Studies at this site

• Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies — Recruiting now
• Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Completed